Health Trials

An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma

ConditionSquamous Cell Carcinoma of Esophagus
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorGuangzhou Institute of Respiratory Disease

About this trial

The purpose of this study is to observe and evaluate the correlation between ctDNA-MRD and the therapeutic effect and prognosis of stage II-IVA operable esophageal squamous cell carcinoma.

Eligibility criteria

Qualifiers

Patients with stage II-IVA Esophageal squamous cell carcinoma confirmed by clinical pathological staging;

≥18 years;

Eastern Cooperative Oncology Group performance status score (ECOG PS) is 0 ~ 1 points;

Expected survival time ≥ 6 months;

Disqualifiers

Patients with other malignant tumors;

Patient had undergone surgery before admission;

Pregnant or lactating women;

Patients with other serious diseases;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Guangzhou Institute of Respiratory Disease

Lead sponsor

Source ClinicalTrials.gov